CagA and VacA seropositivity was not found to elevate the risk of gastric cancer (OR=1.10, 95% CI 0.83–1.47; OR=1.04, 95% CI 0.85–1.28, respectively). The gene discussed is S100A8; the disease is gastric cancer.